Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol
Biohaven’s drug for genetic neurological disease fails late-stage study
The main goal in the Biohaven study measured the change in severity of symptoms among patients who took the drug, troriluzole,…
US FDA lifts hold on Covaxin’s clinical trials
The FDA's earlier decision, in April, to put on hold the trials was based on the US firm's decision to voluntarily implement a…
Pfizer/BioNTech say three COVID shots elicit good response in children under five years of age
The companies said they plan to soon ask global regulators to authorise the shot for the age group, children for whom no vaccine…
Macleod Pharma gets nod for IPO
The firm, which filed its preliminary IPO papers with Sebi between December 2021 and March 2022, obtained Sebi's observations…
SII plans plant in Africa
Africa was the only continent that did not have its own manufacturing capacity for COVID shots during the worst phases of the…
Glenmark launches India’s first Whatsapp-based chatbot
The chatbot, "Hello Skin," will help those people who are suffering from fungal infections
Alembic Pharma receives US FDA final approval for Pirfenidone tablets
Pirfenidone Tablets are indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
Johns Hopkins Bloomberg School of Public Health honours Dr Cyrus S Poonawalla
Dr Poonawalla has been felicitated with Dean’s medal for his life-long contribution with this honour, reserved for luminaries…